Details of Drug

Drug General Information (ID: D1237)
Drug Name	Peginterferon alfa-2a
Drug Type	Interferons
Drug Synonymous	Pegasys; Peginterferon alfa-2a (genetical recombination); Peginterferon alfa-2a (USAN/INN); Peginterferon alfa-2a (genetical recombination) (JAN) Click to Show/Hide
Disease Class	2A82: Mature B-cell leukaemia
Therapeutic Class	Antineoplastics
External Link
	TTD ID	D0Y8OK
	VARIDT ID	DR00472

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM017 CYP450 enzyme inhibition BM043 Additive immunosuppressive effects BM044 Additive myelosuppressive effects BM048 Increased risk of angioedema/anaphylactoid reactions BM055 Increased risk of hepatotoxicity BM069 Increased risk of lowers seizure threshold BM074 Increased risk of peripheral neuropathy BM107 Attenuated pharmacological effects (Unspecific) BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Peginterferon alfa-2a
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 13
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0561		Eltrombopag	C25H22N4O4	135449332	Major		Inter Info	[1], [2], [25]
D1596		Tizanidine	C9H8ClN5S	5487	Major		Inter Info	[43], [44], [45], [46], [47], [48], [49], [50]
D0064		Aminophylline	C16H24N10O4	9433	Moderate		Inter Info	[1], [2], [60], [61], [62], [63], [64], [65], [66]
D0084		Anagrelide	C10H7Cl2N3O	135409400	Moderate		Inter Info	[67]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[68]
D0916		Levobupivacaine	C18H28N2O	92253	Moderate		Inter Info	[2], [111]
D1201		Oxtriphylline	C12H21N5O3	656652	Moderate		Inter Info	[1], [2], [60], [61], [62], [63], [64], [65], [66]
D1292		Pimozide	C28H29F2N3O	16362	Moderate		Inter Info	[127], [128]
D1378		Ramelteon	C16H21NO2	208902	Moderate		Inter Info	[129]
D1385		Rasagiline	C12H13N	3052776	Moderate		Inter Info	[1], [2], [130]
D1427		Ropinirole	C16H24N2O	5095	Moderate		Inter Info	[135], [136]
D1505		Stiripentol	C14H18O3	5311454	Moderate		Inter Info	[2], [138], [139]
D1570		Theophylline	C7H8N4O2	2153	Moderate		Inter Info	[1], [2], [60], [61], [62], [63], [64], [65], [66]
Pharmacodynamic additive effects
	Additive immunosuppressive effects					Drug Num: 24
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0146		Baricitinib	C16H17N7O2S	44205240	Major		Inter Info	[1], [2], [3]
D0348		Cladribine	C10H12ClN5O3	20279	Major		Inter Info	[2], [20]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[26]
D1111		Natalizumab	NA	NA	Major		Inter Info	[35]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[2], [36]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[1], [39]
D1600		Tofacitinib	C16H20N6O	9926791	Major		Inter Info	[51]
D1666		Upadacitinib	C17H19F3N6O	58557659	Major		Inter Info	[54]
D0033		Alemtuzumab	NA	NA	Moderate		Inter Info	[58]
D0136		Azathioprine	C9H7N7O2S	2265	Moderate		Inter Info	[1], [2]
D0443		Denosumab	NA	NA	Moderate		Inter Info	[88]
D0499		Dimethyl fumarate	C6H8O4	637568	Moderate		Inter Info	[89]
D0507		Diroximel fumarate	C11H13NO6	73330464	Moderate		Inter Info	[89]
D1085		Monomethyl fumarate	C5H6O4	5369209	Moderate		Inter Info	[89]
D1140		Niraparib	C19H20N4O	24958200	Moderate		Inter Info	[117]
D1162		Ocrelizumab	NA	NA	Moderate		Inter Info	[118]
D1167		Olaparib	C24H23FN4O3	23725625	Moderate		Inter Info	[2], [119]
D1855		Palifermin	NA	NA	Moderate		Inter Info	[120]
D1422		Roflumilast	C17H14Cl2F2N2O3	449193	Moderate		Inter Info	[2], [134]
D1487		Sodium phosphate, monobasic (p32)	NA	NA	Moderate		Inter Info	[137]
D1509		Strontium chloride Sr-89	Cl2Sr	5388879	Moderate		Inter Info	[1], [2], [140]
D1610		Topotecan	C23H23N3O5	60700	Moderate		Inter Info	[144]
D1671		Ustekinumab	NA	NA	Moderate		Inter Info	[146]
D1720		Zidovudine	C10H13N5O4	35370	Moderate		Inter Info	[1], [2], [147]
	Additive myelosuppressive effects					Drug Num: 5
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0370		Clozapine	C18H19ClN4	135398737	Major		Inter Info	[2], [21], [22]
D0433		Deferiprone	C7H9NO2	2972	Major		Inter Info	[1], [23], [24]
D1443		Samarium (153Sm) lexidronam	Sm	23951	Major		Inter Info	[38]
D0710		Ganciclovir	C9H13N5O4	135398740	Moderate		Inter Info	[1], [2], [96], [97]
D1676		Valganciclovir	C14H22N6O5	135413535	Moderate		Inter Info	[1], [2], [96], [97]
	Increased risk of angioedema/anaphylactoid reactions					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1861		Pegvaliase	C15H30N2O5	86278362	Moderate		Inter Info	[124]
	Increased risk of hepatotoxicity					Drug Num: 24
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[32]
D0944		Lomitapide	C39H37F6N3O2	9853053	Major		Inter Info	[33]
D1073		Mipomersen	C230H324N67O122P19S19	118984467	Major		Inter Info	[34]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[37]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[32]
D0113		Asparaginase Erwinia chrysanthemi	NA	NA	Moderate		Inter Info	[69], [70], [71], [1], [2], [72], [73], [74], [75], [76], [77], [78], [79]
D0114		Asparaginase Escherichia coli	NA	NA	Moderate		Inter Info	[69], [70], [71], [1], [2], [72], [73], [74], [75], [76], [77], [78], [79]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Moderate		Inter Info	[80]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[84], [85]
D0232		Calaspargase pegol	NA	NA	Moderate		Inter Info	[69], [70], [71], [1], [2], [72], [73], [74], [75], [76], [77], [78], [79]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[2], [86]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[87]
D0554		Efavirenz	C14H9ClF3NO2	64139	Moderate		Inter Info	[90], [91]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[1], [2], [92]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[106]
D0826		Interferon beta-1a	NA	NA	Moderate		Inter Info	[107], [108], [109], [110]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[107], [108], [109], [110]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[2], [115]
D1106		Naltrexone	C20H23NO4	5360515	Moderate		Inter Info	[116]
D1234		Pegaspargase	C14H19NO	436058	Moderate		Inter Info	[69], [70], [71], [1], [2], [72], [73], [74], [75], [76], [77], [78], [79]
D1239		Peginterferon beta-1a	NA	NA	Moderate		Inter Info	[107], [108], [109], [110]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[1], [2], [131], [132], [133]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[142], [143]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[2], [145]
	Increased risk of lowers seizure threshold					Drug Num: 11
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0220		Bupropion	C13H18ClNO	444	Major		Inter Info	[5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19]
D0833		Iohexol	C19H26I3N3O9	3730	Major		Inter Info	[27], [28], [29], [30], [31]
D0834		Iopamidol	C17H22I3N3O8	65492	Major		Inter Info	[27], [28], [29], [30], [31]
D1616		Tramadol	C16H25NO2	33741	Major		Inter Info	[52], [18], [17], [53]
D0054		Amifampridine	C5H7N3	5918	Moderate		Inter Info	[56], [59]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[1], [2]
D0722		Ginkgo biloba	NA	NA	Moderate		Inter Info	[98], [99], [100], [101], [102], [103], [104], [105]
D0932		Lindane	C6H6Cl6	727	Moderate		Inter Info	[112], [113], [114]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[125], [126], [2]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[125], [126], [2]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[125], [2], [126]
	Increased risk of peripheral neuropathy					Drug Num: 74
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1543		Telbivudine	C10H14N2O5	159269	Major		Inter Info	[40], [41], [42]
D0614		Etanercept	NA	NA	Moderate		Inter Info	[55], [56], [57]
D0023		Adalimumab	NA	NA	Moderate		Inter Info	[55], [56], [57]
D0066		Amiodarone	C25H29I2NO3	2157	Moderate		Inter Info	[55], [56], [57]
D0120		Atorvastatin	C33H35FN2O5	60823	Moderate		Inter Info	[55], [56], [57]
D0126		Auranofin	C20H34AuO9PS	24199313	Moderate		Inter Info	[55], [56], [57]
D0127		Aurothioglucose	C6H11AuO5S	454937	Moderate		Inter Info	[55], [56], [57]
D0162		Benznidazole	C12H12N4O3	31593	Moderate		Inter Info	[55], [56], [57]
D0193		Bortezomib	C19H25BN4O4	387447	Moderate		Inter Info	[81], [82], [83]
D0227		Cabazitaxel	C45H57NO14	9854073	Moderate		Inter Info	[55], [56], [57]
D0260		Carboplatin	C6H12N2O4Pt	426756	Moderate		Inter Info	[55], [56], [57]
D0261		Carfilzomib	C40H57N5O7	11556711	Moderate		Inter Info	[55], [56], [57]
D0303		Cerivastatin	C26H34FNO5	446156	Moderate		Inter Info	[55], [56], [57]
D0304		Certolizumab pegol	NA	NA	Moderate		Inter Info	[55], [56], [57]
D0313		Chloramphenicol	C11H12Cl2N2O5	5959	Moderate		Inter Info	[55], [56], [57]
D0320		Chloroquine	C18H26ClN3	2719	Moderate		Inter Info	[55], [56], [57]
D0344		Cisplatin	Cl2H6N2Pt	5702198	Moderate		Inter Info	[55], [56], [57]
D0380		Colchicine	C22H25NO6	6167	Moderate		Inter Info	[55], [56], [57]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Moderate		Inter Info	[55], [56], [57]
D0419		Dapsone	C12H12N2O2S	2955	Moderate		Inter Info	[55], [56], [57]
D0483		Didanosine	C10H12N4O3	135398739	Moderate		Inter Info	[55], [56], [57]
D0496		Diiodohydroxyquinoline	C9H5I2NO	3728	Moderate		Inter Info	[55], [56], [57]
D0501		Dinutuximab	NA	NA	Moderate		Inter Info	[55], [56], [57]
D0509		Disulfiram	C10H20N2S4	3117	Moderate		Inter Info	[55], [56], [57]
D0511		Docetaxel	C43H53NO14	148124	Moderate		Inter Info	[55], [56], [57]
D0560		Elotuzumab	NA	NA	Moderate		Inter Info	[55], [56], [57]
D0571		Enfortumab vedotin	NA	NA	Moderate		Inter Info	[55], [56], [57]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[55], [56], [57]
D0616		Ethambutol	C10H24N2O2	14052	Moderate		Inter Info	[55], [56], [57]
D1731		Ethionamide	C8H10N2S	2761171	Moderate		Inter Info	[55], [56], [57]
D0627		Etoposide	C29H32O13	36462	Moderate		Inter Info	[55], [56], [57]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[55], [56], [57]
D0669		Fludarabine	C10H12FN5O4	657237	Moderate		Inter Info	[55], [56], [57]
D0686		Fluvastatin	C24H26FNO4	446155	Moderate		Inter Info	[55], [56], [57]
D0770		Hydralazine	C8H8N4	3637	Moderate		Inter Info	[55], [56], [57]
D0802		Infliximab	NA	NA	Moderate		Inter Info	[55], [56], [57]
D0821		Interferon alfa-2a, Recombinant	NA	NA	Moderate		Inter Info	[55], [56], [57]
D0822		Interferon alfa-2b	C16H17Cl3I2N3NaO5S	71306834	Moderate		Inter Info	[55], [56], [57]
D0824		Interferon alfa-n1	NA	NA	Moderate		Inter Info	[55], [56], [57]
D0823		Interferon alfacon-1	NA	NA	Moderate		Inter Info	[55], [56], [57]
D0841		Ipilimumab	NA	NA	Moderate		Inter Info	[55], [56], [57]
D0858		Isoniazid	C6H7N3O	3767	Moderate		Inter Info	[55], [56], [57]
D0873		Ixabepilone	C27H42N2O5S	6445540	Moderate		Inter Info	[55], [56], [57]
D0874		Ixazomib	C14H19BCl2N2O4	25183872	Moderate		Inter Info	[55], [56], [57]
D0918		Levodopa	C9H11NO4	6047	Moderate		Inter Info	[55], [56], [57]
D0933		Linezolid	C16H20FN3O4	441401	Moderate		Inter Info	[55], [56], [57]
D0956		Lovastatin	C24H36O5	53232	Moderate		Inter Info	[55], [56], [57]
D1113		Naxitamab	NA	NA	Moderate		Inter Info	[55], [56], [57]
D1118		Nelarabine	C11H15N5O5	3011155	Moderate		Inter Info	[55], [56], [57]
D1145		Nitrofurantoin	C8H6N4O5	6604200	Moderate		Inter Info	[55], [56], [57]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[55], [56], [57]
D1212		Paclitaxel	C47H51NO14	36314	Moderate		Inter Info	[55], [56], [57]
D1213		Paclitaxel (protein-bound)	C47H51NO14	36314	Moderate		Inter Info	[55], [56], [57]
D1238		Peginterferon alfa-2b	NA	NA	Moderate		Inter Info	[55], [56], [57]
D1301		Pitavastatin	C25H24FNO4	5282452	Moderate		Inter Info	[55], [56], [57]
D1306		Polatuzumab vedotin	NA	NA	Moderate		Inter Info	[55], [56], [57]
D1312		Pomalidomide	C13H11N3O4	134780	Moderate		Inter Info	[55], [56], [57]
D1313		Ponatinib	C29H27F3N6O	24826799	Moderate		Inter Info	[55], [56], [57]
D1329		Pravastatin	C23H36O7	54687	Moderate		Inter Info	[55], [56], [57]
D1430		Rosuvastatin	C22H28FN3O6S	446157	Moderate		Inter Info	[55], [56], [57]
D1452		Secnidazole	C7H11N3O3	71815	Moderate		Inter Info	[55], [56], [57]
D1473		Simvastatin	C25H38O5	54454	Moderate		Inter Info	[55], [56], [57]
D1479		Sodium aurothiomalate	C4H3AuNa2O4S	22318	Moderate		Inter Info	[55], [56], [57]
D1504		Stavudine	C10H12N2O4	18283	Moderate		Inter Info	[55], [56], [57]
D1551		Teniposide	C32H32O13S	452548	Moderate		Inter Info	[55], [56], [57]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[81], [1], [2], [141]
D1587		Tinidazole	C8H13N3O4S	5479	Moderate		Inter Info	[55], [56], [57]
D1599		Tocilizumab	NA	NA	Moderate		Inter Info	[55], [56], [57]
D1623		Trastuzumab emtansine	NA	NA	Moderate		Inter Info	[55], [56], [57]
D1697		Vinblastine	C46H58N4O9	13342	Moderate		Inter Info	[55], [56], [57]
D1698		Vincristine	C46H56N4O10	5978	Moderate		Inter Info	[55], [56], [57]
D1699		Vincristine (liposome)	C46H56N4O10	5978	Moderate		Inter Info	[55], [56], [57]
D1700		Vinorelbine	C45H54N4O8	5311497	Moderate		Inter Info	[55], [56], [57]
D1714		Zafirlukast	C31H33N3O6S	5717	Moderate		Inter Info	[55], [56], [57]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0178		Bexarotene	C24H28O2	82146	Major		Inter Info	[2], [4]
Pharmacodynamic antagonistic effects
	Attenuated pharmacological effects (Unspecific)					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0659		Filgrastim	NA	NA	Moderate		Inter Info	[93], [94], [95]
D1235		Pegfilgrastim	C27H46N4O19	70683024	Moderate		Inter Info	[121], [122]
D1860		Pegloticase	NA	NA	Moderate		Inter Info	[123]
D1446		Sargramostim	NA	NA	Moderate		Inter Info	[93], [94], [95]

References
1	Cerner Multum, Inc. "Australian Product Information.".
2	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
3	Product Information. Olumiant (baricitinib). Lilly, Eli and Company, Indianapolis, IN.
4	Product Information. Targretin (bexarotene) Ligand Pharmaceuticals, San Diego, CA.
5	Product Information. Wellbutrin XL (buPROPion). GlaxoSmithKline, Philadelphia, PA.
6	Sheehan DV, Welch JB, Fishman SM "A case of bupropion-induced seizure." J Nerv Ment Dis 174 (1986): 496-8. [PMID: 3090199]
7	Canadian Pharmacists Association.
8	Product Information. Wellbutrin (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
9	Gittelman DK, Kirby MG "A seizure following bupropion overdose." J Clin Psychiatry 54 (1993): 162. [PMID: 8486598]
10	Product Information. Wellbutrin SR (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
11	James WA, Lippmann S "Bupropion: overview and prescribing guidelines in depression." South Med J 84 (1991): 222-4. [PMID: 1899294]
12	Masco HL, Kiev A, Holloman LC, Batey SR, Johnston JA, Lineberry CG "Safety and efficacy of bupropion and nortriptyline in outpatients with depression." Curr Ther Res Clin Exp 55 (1994): 851-63.
13	Dufresne RL, Weber SS, Becker RE "Bupropion hydrochloride." Drug Intell Clin Pharm 18 (1984): 957-64. [PMID: 6439541]
14	Product Information. Zyban (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
15	Storrow AB "Bupropion overdose and seizure." Am J Emerg Med 12 (1994): 183-4. [PMID: 8161393]
16	Johnston JA, Lineberry CG, Ascher JA, et al. "A 102-center prospective study of seizure in association with bupropion." J Clin Psychiatry 52 (1991): 450-6. [PMID: 1744061]
17	Rosenstein DL, Nelson JC, Jacobs SC "Seizures associated with antidepressants: a review." J Clin Psychiatry 54 (1993): 289-99. [PMID: 8253696]
18	Pisani F, Spina E, Oteri G "Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice." Epilepsia 40(Suppl 10) (1999): S48-56. [PMID: 10609604]
19	Product Information. Aplenzin (buPROPion). sanofi-aventis , Bridgewater, NJ.
20	Product Information. Leustatin (cladribine). Ortho Biotech Inc, Raritan, NJ.
21	Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
22	Canadian Pharmacists Association "e-CPS."
23	Product Information. Ferriprox (deferiprone). ApoPharma USA Inc, Rockville, MD.
24	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports."
25	Product Information. Promacta (eltrombopag). GlaxoSmithKline, Research Triangle Park, NC.
26	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
27	Product Information. Isovue-M-200 (iopamidol). Bracco Diagnostics Inc, Princeton, NJ.
28	Product Information. Amipaque (metrizamide) Nycomed Inc, Princeton, NJ.
29	Hindmarsh T, Grepe A, Widen L "Metrizamide-phenothiazine interaction: report of a case with seizures following myelography." Acta Radiol Diagn (Stockh) 16 (1975): 129-35. [PMID: 810000]
30	Product Information. Omnipaque 180 (iohexol). Amersham Health, Princeton, NJ.
31	Product Information. Osmovist 240 (iotrolan). Berlex Canada Inc, Lachine, QC.
32	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
33	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
34	Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
35	Product Information. Tysabri (natalizumab). Elan Pharmaceutical/Athena Neurosciences Inc, South San Francisco, CA.
36	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
37	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
38	Product Information. Quadramet (samarium sm 153 lexidronam) Berlex Laboratories, Richmond, CA.
39	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
40	Product Information. PEG-Intron (peginterferon alfa-2b) Schering Corporation, Kenilworth, NJ.
41	Product Information. Pegasys (peginterferon alfa-2a). Roche Laboratories, Nutley, NJ.
42	Product Information. Tyzeka (telbivudine). IDEC Pharmaceuticals Corporation, San Diego, CA.
43	Granfors MT, Backman JT, Laitila J, Neuvonen PJ "Tizanidine is mainly metabolized by cytochrome P450 1A2 in vitro." Br J Clin Pharmacol 57 (2004): 349-53. [PMID: 14998432]
44	Granfors MT, Backman JT, Neuvonen M, Ahonen J, Neuvonen PJ "Fluvoxamine drastically increases concentrations and effects of tizanidine: A potentially hazardous interaction." Clin Pharmacol Ther 75 (2004): 331-41. [PMID: 15060511]
45	Granfors MT, Backman JT, Neuvonen M, Neuvonen PJ "Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism." Clin Pharmacol Ther 76 (2004): 598-606. [PMID: 15592331]
46	Momo K, Doki K, Hosono H, Homma M, Kohda Y "Drug interaction of tizanidine and fluvoxamine." Clin Pharmacol Ther 76 (2004): 509-10. [PMID: 15536467]
47	Momo K, Homma M, Kohda Y, Ohkoshi N, Yoshizawa T, Tamaoka A "Drug interaction of tizanidine and ciprofloxacin: Case report." Clin Pharmacol Ther 80 (2006): 717-9. [PMID: 17178273]
48	Product Information. Vioxx (rofecoxib). Merck & Co, Inc, West Point, PA.
49	Product Information. Zanaflex (tizanidine). Acorda Therapeutics, Hawthorne, NY.
50	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
51	Product Information. Xeljanz (tofacitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
52	Product Information. Ultram (tramadol). McNeil Pharmaceutical, Raritan, NJ.
53	Gardiner JS, Blough D, Drinkard CR, et al. "Tramadol and seizures: a surveillance study in a managed care population." Pharmacotherapy 20 (2000): 1423-31. [PMID: 11130214]
54	Product Information. Rinvoq (upadacitinib). AbbVie US LLC, North Chicago, IL.
55	Carrion C, Espinosa E, Herrero A, Garcia B "Possible vincristine-isoniazid interaction." Ann Pharmacother 29 (1995): 201. [PMID: 7756727]
56	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
57	Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online."
58	Product Information. Campath (alemtuzumab) Berlex, Richmond, CA.
59	Product Information. Firdapse (amifampridine). Catalyst Pharmaceuticals, Inc., Coral Gables, FL.
60	Jonkman JH, Nicholson KG, Farrow PR, et al "Effects of alpha-interferon on theophylline pharmacokinetics and metabolism." Br J Clin Pharmacol 27 (1989): 795-802. [PMID: 2757895]
61	Kramer P, Tsuru M, Cook CE, et al "Effect of influenza vaccine on warfarin anticoagulation." Clin Pharmacol Ther 35 (1984): 416-8. [PMID: 6697649]
62	Okuno H, Takasu M, Kano H, Seki T, Shiozaki Y, Inoue K "Depression of drug-metabolizing activity in the human liver by interferon-beta." Hepatology 17 (1993): 65-9. [PMID: 8423043]
63	Product Information. Intron A (interferon alfa-2b). Schering Laboratories, Kenilworth, NJ.
64	Sakai H, Okamoto T, Kikkawa Y "Suppression of hepatic drug metabolism by the interferon inducer polyriboinosinic acid:polyribocitidylic acid." J Pharmacol Exp Ther 263 (1992): 381-6. [PMID: 1403800]
65	Upton RA "Pharmacokinetic interactions between theophylline and other medication (Part II)." Clin Pharmacokinet 20 (1991): 135-50. [PMID: 1709398]
66	Williams SJ, Baird-Lambert JA, Farrell GC "Inhibition of theophylline metabolism by interferon." Lancet 10/24/87 (1987): 939-41. [PMID: 2444839]
67	Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
68	Product Information. Saphris (asenapine). Schering-Plough Corporation, Kenilworth, NJ.
69	Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
70	Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
71	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
72	Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
73	Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
74	Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
75	Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
76	Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
77	Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
78	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
79	Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
80	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
81	Argov Z, Mastaglia FL "Drug-induced peripheral neuropathies." Br Med J 1 (1979): 663-6. [PMID: 219931]
82	Cavaletti G, Jakubowiak AJ "Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies." Leuk Lymphoma 51 (2010): 1178-87. [PMID: 20497001]
83	Product Information. Velcade (bortezomib). Millennium Pharmaceuticals Inc, Cambridge, MA.
84	Product Information. Accolate (zafirlukast). Zeneca Pharmaceuticals, Wilmington, DE.
85	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
86	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
87	Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
88	Product Information. Prolia (denosumab). Amgen USA, Thousand Oaks, CA.
89	Product Information. Vumerity (diroximel fumarate). Alkermes, Inc, Cambridge, MA.
90	Elsharkawy AM, Schwab U, McCarron B, et al. "Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser." J Clin Virol 58 (2013): 331-3. [PMID: 23763943]
91	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
92	Product Information. Ellence (epirubicin) Pharmacia and Upjohn, Kalamazoo, MI.
93	Product Information. Granix (tbo-filgrastim). Teva Pharmaceuticals USA, North Wales, PA.
94	Product Information. Leukine (sargramostim). Immunex Corporation, Seattle, WA.
95	Product Information. Stemgen (ancestim) Amgen, Thousand Oaks, CA.
96	Product Information. Cytovene (ganciclovir). Genentech, South San Francisco, CA.
97	Product Information. Valcyte (valganciclovir) Roche Laboratories, Nutley, NJ.
98	Kajiyama Y, Fujii K, Takeuchi H, Manabe Y "Ginkgo seed poisoning." Pediatrics 109 (2002): 325-7. [PMID: 11826216]
99	Granger AS "Ginkgo biloba precipitating epileptic seizures." Age Ageing 30 (2001): 523-5. [PMID: 11742783]
100	Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11. [PMID: 9818800]
101	Spinella M "Herbal medicines and epilepsy: the potential for benefit and adverse effects." Epilepsy Behav 2 (2001): 524-32. [PMID: 12609386]
102	Gregory PJ "Seizure associated with Ginkgo biloba?." Ann Intern Med 134 (2001): 344. [PMID: 11182853]
103	Harms SL, Garrard J, Schwinghammer P, Eberly LE, Chang Y, Leppik IE "Ginkgo biloba use in nursing home elderly with epilepsy or seizure disorder." Epilepsia 47 (2006): 323-9. [PMID: 16499756]
104	Miwa H, Iijima M, Tanaka S, Mizuno Y "Generalized convulsions after consuming a large amount of Gingko nuts." Epilepsia 42 (2001): 280-1. [PMID: 11240603]
105	Kupiec T, Raj V "Fatal seizures due to potential herb-drug interactions with Ginkgo biloba." J Anal Toxicol 29 (2005): 755-8. [PMID: 16419414]
106	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
107	Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
108	Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
109	Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
110	Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
111	Product Information. Chirocaine (levobupivacaine) Organon, West Orange, NJ.
112	Matsuoka LY "Convulsions following application of gamma benzene hexachloride." J Am Acad Dermatol 5 (1981): 98-9. [PMID: 6168673]
113	Cox R, Krupnick J, Bush N, Houpt A "Seizures caused by concomitant use of lindane and dextroamphetamine in a child with attention deficit hyperactivity disorder." J Miss State Med Assoc 41 (2000): 690-2. [PMID: 10974795]
114	Product Information. Kwell (lindane). Reed and Carnrick, Jersey City, NJ.
115	Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
116	Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
117	Product Information. Zejula (niraparib). Tesaro Inc., Waltham, MA.
118	Product Information. Ocrevus (ocrelizumab). Genentech, South San Francisco, CA.
119	Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
120	Product Information. Kepivance (palifermin). Shire US Inc, Florence, KY.
121	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
122	Product Information. Neulasta (pegfilgrastim). Amgen, Thousand Oaks, CA.
123	Product Information. Krystexxa (pegloticase). Savient Pharmaceuticals, East Brunswick, NJ.
124	Product Information. Palynziq (pegvaliase). BioMarin Pharmaceutical Inc, Novato, CA.
125	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
126	Salik JM, Kurtin P "Severe hyponatremia after colonoscopy preparation in a patient with the acquired immune deficiency syndrome." Am J Gastroenterol 80 (1985): 177-9. [PMID: 2983533]
127	Krahenbuhl S, Sauter B, Kupferschmidt H, Krause M, Wyss PA, Meier PJ "Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication." Am J Med Sci 309 (1995): 315-6. [PMID: 7771501]
128	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
129	Product Information. Rozerem (ramelteon). Takeda Pharmaceuticals America, Lincolnshire, IL.
130	Product Information. Azilect (rasagiline). Teva Pharmaceuticals USA, North Wales, PA.
131	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
132	Gilead Sciences, Inc "About Remdesivir.".
133	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
134	Product Information. Daxas (roflumilast). Nycomed Inc, Princeton, NJ.
135	Product Information. Noroxin (norfloxacin). Merck & Co, Inc, West Point, PA.
136	Product Information. Requip (ropinirole). SmithKline Beecham, Philadelphia, PA.
137	AnazaoHealth Corporation "P32 Sodium Phosphate."
138	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
139	Product Information. Diacomit (stiripentol). Biocodex Inc, Creswell, OR.
140	Multum Information Services, Inc. Expert Review Panel.
141	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
142	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
143	Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
144	Product Information. Hycamtin (topotecan). SmithKline Beecham, Philadelphia, PA.
145	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
146	Product Information. Stelara (ustekinumab). Centocor Inc, Malvern, PA.
147	Product Information. Retrovir (zidovudine). Glaxo Wellcome, Research Triangle Park, NC.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence